A qualified Chartered Certified Accountant and a lover of classical music, my other great passion in life is the trading of shares. Always on the look out for under the radar stocks with great potential, I tend to focus on biotech companies but consider all potential hidden gems.
Ian Bezek worked for 3 years as an analyst at a New York-based hedge fund. He's currently living in Mexico, pursuing some entrepreneurial opportunities.
Feel free to contact him regarding investments, writing, or speaking opportunities.
Elderly pharmacist from Grand Rapids MI. Became interested in investing after '08 when I found out brokers are pretty much only interested in themselves and not your money. Greatest interest in Pharma and Biotech.
Andrew McDonald is a healthcare investment professional with expertise in identifying transformative medicines as well as in forecasting clinical trial, regulatory, and sales outcomes. Prior to co-founding LifeSci Advisors, Andrew most recently served as senior biotechnology analyst at Great Point Partners, a dedicated life science hedge fund. From 2004-2006, Andrew was Co-head of Healthcare Research and Biotechnology Analyst at ThinkEquity Partners, a boutique investment bank. Prior to entering the financial services industry, Andrew was a medicinal chemist at Cytokinetics from 2001-2004, where he discovered and developed a promising anti-cancer agent now in clinical trials. Andrew began his pharmaceutical career as a medicinal chemist at Pfizer from 2000-2001. Andrew received a Ph.D. in organic chemistry from UC Irvine and completed his B.S. in chemistry at UC Berkeley.
Larry White is a featured analyst at ElliottWaveTrader focusing on mining stocks. Larry joined as a member of EWT in October 2012 and quickly shifted his focus to mining stocks as well as the GDX and GDXJ mining ETFs. Prior to trading, held management and executive roles for organizations such as Toshiba, ISOETEC, and Panasonic.
I obtained my PhD in 2009 working in Dr. Suzie Pun's lab at the University of Washington. I studied polymer-based DNA delivery in graduate school, I worked on the siRNA delivery effort at Merck, and now I am working on Antibody-RNA Conjugates for Avidity Nanomedicines.